A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients

NCT06237777 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

GENETIC: SKG0106 intravitreal injection dose level 1, 2 or 3

Sponsor

Wang Min

Collaborators

[object Object]